1h Free Analyst Time
The nerve repair and regeneration market is forecasted to grow by USD 6.80 billion during 2023-2028, accelerating at a CAGR of 13.47% during the forecast period. The report on the nerve repair and regeneration market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of neurological disorders, increasing government funds for research on neurological diseases, and expansion of neurology-related research projects.
The nerve repair and regeneration market is segmented as below:
By Product
- Neuromodulation devices
- Biomaterials
By Application
- Neurorrhaphy
- Nerve grafting
- STEM cell therapy
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the nerve repair and regeneration market covers the following areas:
- Nerve repair and regeneration market sizing
- Nerve repair and regeneration market forecast
- Nerve repair and regeneration market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global nerve repair and regeneration market: Abbott Laboratories, ALEVA NEUROTHERAPEUTICS SA, AxoGen Inc, Baxter International Inc., BioWave Ltd., Boston Scientific Corp., Check Point Surgical Inc., Collagen Matrix Inc., Gimer Medical Co. Ltd., Integra Lifesciences Corp., KeriMedical SA, LivaNova PLC, Medtronic Plc, NEURONETICS Inc., NeuroPace Inc., NeuroSigma Inc., Polyganics BV, Soterix Medical Inc., Stryker Corp., and Synapse Biomedical Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is technological advancements for nerve repair and regeneration."
According to the report, one of the major drivers for this market is the rising prevalence of neurological disorders.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- ALEVA NEUROTHERAPEUTICS SA
- AxoGen Inc
- Baxter International Inc.
- BioWave Ltd.
- Boston Scientific Corp.
- Check Point Surgical Inc.
- Collagen Matrix Inc.
- Gimer Medical Co. Ltd.
- Integra Lifesciences Corp.
- KeriMedical SA
- LivaNova PLC
- Medtronic Plc
- NEURONETICS Inc.
- NeuroPace Inc.
- NeuroSigma Inc.
- Polyganics BV
- Soterix Medical Inc.
- Stryker Corp.
- Synapse Biomedical Inc.
